3 Key Takeaways
Plain English Summary- 01Core Finding
We identified the most recent national NCCP for each country from the International Cancer Control Partnership repository, the WHO Noncommunicable Disease Document Repository, and government websites; sub-national plans, broader non-communicable disease or health-sector strategies, drafts, and superseded versions were excluded.
- 02Study Evidence
Tested in a observational cohort study (31 participants) at the real-world cohort stage.
- 03Practical Meaning
Observational cohort findings reveal real-world links, though lifestyle or unmeasured factors cannot be fully ruled out without an RCT.
What This Means for You
Our analysis suggests that NCCP comprehensiveness varies substantially between countries with consistent weaknesses in financing, outcome measurement, and contextual analysis. A shared health systems framework and scalable AI appraisal tools, such as PRISM, could support more complete, comparable, and actionable plans to strengthen cancer control globally by providing the possibility for rapid analysis of comprehensiveness of NCCPs and generation of timely, achievable, and evidence-informed, context-specific plans that use the latest data.
The Discovery
National cancer control plans (NCCPs) vary in scope and comprehensiveness, yet expert-led review is resource intensive and limits cross-country comparability. We aimed to assess NCCP comprehensiveness across 50 countries using the policy reasoning integrated sequential model (PRISM), a validated multiagent artificial intelligence (AI) system. We identified the most recent national NCCP for each country from the International Cancer Control Partnership repository, the WHO Noncommunicable Disease Document Repository, and government websites; sub-national plans, broader non-communicable disease or health-sector strategies, drafts, and superseded versions were excluded. We developed an analytical framework of 12 elements and 76 sub-elements, aligned with WHO, International Cancer Control Partnership, and Union for International Cancer Control guidance and validated it through a modified two-stage Delphi process (online survey of 67 experts; triangulation workshop with 31 participants). PRISM comprised document ingestion (Qwen2.5-VL-72B), policy analysis with retrieval-augmented generation (Llama 4 Scout, 109B), and semantic quality assurance. PRISM was validated against masked dual-expert ratings for six purposely selected NCCPs, then applied to all NCCPs. Scores were normalised to 0-5 and medians compared across World Bank income group and WHO region. We identified 50 NCCPs that met the inclusion criteria. Median overall comprehensiveness was 2·78 (IQR 2·25-3·09), with high comprehensiveness classified as 4·0-5·0, moderate as 2·0-3·9, and low as 0-1·9. Europe (2·96; 2·78-3·35) and lower-middle-income countries (2·97; 2·48-3·15) had the highest medians; the western Pacific (2·21; 1·78-2·87) and low-income countries (2·05; 1·94-2·22) had the lowest. Element-level medians were highest for implementation (4·17; 3·54-4·38), health services (3·89; 2·63-4·19), and governance and organisation (3·67; 3·35-3·98), and lowest for financing (1·88; 1·00-2·69), outcomes (1·83; 1·33-2·33), and threats (2·19; 1·72-2·34). Financing showed the largest gaps-only five of eleven financing sub-elements had median scores of 1·0 or less.
How It Works, Simply
This oncology research focuses on AI model. Researchers evaluated it using an observational cohort study (31 participants) at the real-world cohort stage of medical research.
3 Key Takeaways
Clinical Takeaways- 01Core Finding
We identified the most recent national NCCP for each country from the International Cancer Control Partnership repository, the WHO Noncommunicable Disease Document Repository, and government websites; sub-national plans, broader non-communicable disease or health-sector strategies, drafts, and superseded versions were excluded.
- 02Study Evidence
Tested in a observational cohort study (31 participants) at the real-world cohort stage.
- 03Practical Meaning
Observational cohort findings reveal real-world links, though lifestyle or unmeasured factors cannot be fully ruled out without an RCT.
Biological Mechanism & Study Design
Study Design & Cohort
Observational cohort study
Observational cohort study (31 participants) · Real-World Cohort
Biological Pathway & Modality
AI model
Intervention: Assessment of comprehensiveness of national cancer control plans using a multiagent
Experimental Findings & Endpoints
National cancer control plans (NCCPs) vary in scope and comprehensiveness, yet expert-led review is resource intensive and limits cross-country comparability.
We aimed to assess NCCP comprehensiveness across 50 countries using the policy reasoning integrated sequential model (PRISM), a validated multiagent artificial intelligence (AI) system. We identified the most recent national NCCP for each country from the International Cancer Control Partnership repository, the WHO Noncommunicable Disease Document Repository, and government websites; sub-national plans, broader non-communicable disease or health-sector strategies, drafts, and superseded versions were excluded.
We developed an analytical framework of 12 elements and 76 sub-elements, aligned with WHO, International Cancer Control Partnership, and Union for International Cancer Control guidance and validated it through a modified two-stage Delphi process (online survey of 67 experts; triangulation workshop with 31 participants). PRISM comprised document ingestion (Qwen2.5-VL-72B), policy analysis with retrieval-augmented generation (Llama 4 Scout, 109B), and semantic quality assurance.
PRISM was validated against masked dual-expert ratings for six purposely selected NCCPs, then applied to all NCCPs. Scores were normalised to 0-5 and medians compared across World Bank income group and WHO region.
We identified 50 NCCPs that met the inclusion criteria. Median overall comprehensiveness was 2·78 (IQR 2·25-3·09), with high comprehensiveness classified as 4·0-5·0, moderate as 2·0-3·9, and low as 0-1·9.
Europe (2·96; 2·78-3·35) and lower-middle-income countries (2·97; 2·48-3·15) had the highest medians; the western Pacific (2·21; 1·78-2·87) and low-income countries (2·05; 1·94-2·22) had the lowest. Element-level medians were highest for implementation (4·17; 3·54-4·38), health services (3·89; 2·63-4·19), and governance and organisation (3·67; 3·35-3·98), and lowest for financing (1·88; 1·00-2·69), outcomes (1·83; 1·33-2·33), and threats (2·19; 1·72-2·34).
Financing showed the largest gaps-only five of eleven financing sub-elements had median scores of 1·0 or less.
Clinical Translation & Practice Context
Our analysis suggests that NCCP comprehensiveness varies substantially between countries with consistent weaknesses in financing, outcome measurement, and contextual analysis.
A shared health systems framework and scalable AI appraisal tools, such as PRISM, could support more complete, comparable, and actionable plans to strengthen cancer control globally by providing the possibility for rapid analysis of comprehensiveness of NCCPs and generation of timely, achievable, and evidence-informed, context-specific plans that use the latest data.
The Bottom Line · Clinical Pearl
“Our analysis suggests that NCCP comprehensiveness varies substantially between countries with consistent weaknesses in financing, outcome measurement, and contextual analysis.”
Published in The Lancet Oncology · Current Stage: Real-World Cohort